<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00488423</url>
  </required_header>
  <id_info>
    <org_study_id>8585</org_study_id>
    <nct_id>NCT00488423</nct_id>
    <nct_alias>NCT00554593</nct_alias>
  </id_info>
  <brief_title>Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery</brief_title>
  <acronym>MIDAS</acronym>
  <official_title>Glucose Metabolism in the Immediate and Short Term Follow up From Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      MIDAS involves an assessment of glucose levels obtained before and after bariatric surgery.
      There are two different procedural tests involved; an oral glucose tolerance test (mixed
      meal) and a hyperglycemic clamp test. Two tests are performed preoperatively and five more
      are performed postoperatively for a one year period. The associated labwork drawn with the
      mixed meal and clamp tests are demonstrating changes in glucose, insulin and gut hormone
      levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tests performed are the Mixed Meal tolerance test, the Hyperglycemic Clamp test, c-peptide,
      free fatty acids, adipocyte hormone profile levels.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">November 2008</completion_date>
  <primary_completion_date type="Actual">November 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the effect of gastric by-pass surgery to decrease lipotoxicity.</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To examine the effect of roux-en-Y compared to gastric banding on pancreatic B cell recovery or insulin secretion in response to oral and IV glucose.</measure>
    <time_frame>One Year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Diabetes</condition>
  <condition>Gastric Bypass</condition>
  <arm_group>
    <arm_group_label>Lap-band</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient undergoing Lap-band Bariatric Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Gastric Bypass</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient's undergoing Laparoscopic Roux-N Y Gastric Bypass surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mixed Meal Tolerance test, Hyperglycemic clamp</intervention_name>
    <description>Subjects undergo a standard mixed meal tolerance test &amp; hyperglycemic clamp to assess insulin secretion &amp; sensitivity (whole body glucose disposal) pre-op. Following surgery, at 1week, 1 month, 6 months and 12 months subjects will undergo hyperglycemic clamp &amp; mixed meal tolerance test. During these tests, measurements will include plasma levels of glucose, insulin, C-peptide, free fatty acid levels and adipocyte hormone profile (adiponectin, leptin, resistin). A gut hormone profile (ghrelin, glucagons-like-peptide 1 GLP-1, glucose-dependent insulinotropic polypeptide GIP, PYY) will be performed at fasting &amp; specific postprandial times. Results will be compared between two groups: patients undergoing laparoscopic Roux-en-Y gastric bypass &amp; gastric banding.</description>
    <arm_group_label>Lap-band</arm_group_label>
    <arm_group_label>Gastric Bypass</arm_group_label>
    <other_name>MMTT</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Negative pregnancy test if female

          -  ADA criteria for diabetes type II

          -  Hematocrit &gt; 35 creatinine &lt; 1.9, AST &lt; 3X upper limit of normal, ALT &lt; 3X upper limit
             of normal, alkaline phos &lt;3X upper limit of normal

          -  Eligibility for bariatric surgery based on the NIH and clinical criteria

          -  Mentally and legally capable of providing consent

        Exclusion Criteria:

          -  Lactating females

          -  Must not have type I diabetes

          -  Systemic steroids taken within 6 months

          -  Clinically significant heart disease

          -  Recent pulmonary embolism, untreated proliferative retinopathy, renal failure,
             uncontrolled hypertension, autonomic neuropathy, resting heart rate &gt; 100,
             neuromuscular or musculoskeletal disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sangeeta R. Kashyap, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philip R. Schauer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2007</study_first_submitted>
  <study_first_submitted_qc>June 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 20, 2007</study_first_posted>
  <last_update_submitted>June 21, 2011</last_update_submitted>
  <last_update_submitted_qc>June 21, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Cleveland Clinic Foundation</name_title>
    <organization>Endocrine &amp; Metabolic Institute Research</organization>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>MIDAS</keyword>
  <keyword>gut hormones</keyword>
  <keyword>gastric bypass</keyword>
  <keyword>lap band</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

